Regencell Bioscience Holdings Limited (RGC)
RGC
7.67
-2.16 (-22.01%)
FUNDAMENTALS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Market Cap$3.80B
P/E Ratio—
52W High69.00
52W Low4.51
Dividend Yield—
ANALYSIS
SMA 207.99
SMA 506.68
Volatility (ann.)120.9%
RSI (14)52.58
Beta (vs SPY)1.18
MACD (12,26,9)0.87 / 0.8
Bollinger (20,2)4.97 – 11.01
FINANCIALS — QUARTERLY
No financial statement data available.
EARNINGS
Next Earnings DateOct 28, 2026
No earnings history available.
ANALYST COVERAGE
Price Target (mean)—
Target Range
—
OWNERSHIP & INSIDERS
Insiders88.55%
Institutions0.29%
Short % of Float1.16%
Short Ratio3.95
TOP INSTITUTIONAL HOLDERS
Geode Capital Management, LLC0.09%
Alyeska Investment Group, L.p.0.08%
Legal & General Group PLC0.03%
Jane Street Group, LLC0.02%
Quadrature Capital Ltd0.01%
RECENT INSIDER TRANSACTIONS
No insider transactions available.
NEWS
No headlines yet.